• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肾透明细胞癌中异常DNA甲基化鉴定预后生物标志物。

Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.

作者信息

Chen Guang, Wang Yihan, Wang Lu, Xu Wanhai

机构信息

Department of Urology, The 4th Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.

出版信息

Oncotarget. 2017 Jan 17;8(3):5268-5280. doi: 10.18632/oncotarget.14134.

DOI:10.18632/oncotarget.14134
PMID:28029655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5354907/
Abstract

The outcome of kidney renal clear cell carcinoma (KIRC) differs even among individuals with similar clinical characteristics. DNA methylation is regarded as a regulator of gene expression in cancers, which may be a molecular marker of prognosis. In this study, we aimed to mine novel methylation markers of the prognosis of KIRC. We revealed a total of 2793 genes differentially methylated in their promoter regions (DMGs) and 2979 differentially expressed genes (DEGs) in KIRC tissues compared with normal tissues using The Cancer Genome Atlas datasets. Then, we detected 57 and 34 subpathways enriched among the DMGs and DEGs, respectively, using the R package iSubpathwayMiner. We retained 56 subpathways related to both aberrant methylation and expression based on a hypergeometric test for further analysis. An integrated gene regulatory network was constructed using the regulatory relationships between genes in the subpathways. Using the top 15% of the nodes from the network ranked by degree, survival analysis was performed. We validated four DNA methylation signatures (RAC2, PLCB2, VAV1, and PARVG) as being highly correlated with prognosis in KIRC. These findings suggest that DNA methylation might become a prognostic predictor in KIRC and could supplement histological prognostic prediction.

摘要

肾透明细胞癌(KIRC)的预后即使在具有相似临床特征的个体之间也存在差异。DNA甲基化被认为是癌症中基因表达的调节因子,可能是一种预后的分子标志物。在本研究中,我们旨在挖掘KIRC预后的新型甲基化标志物。使用癌症基因组图谱数据集,我们发现与正常组织相比,KIRC组织中共有2793个基因在其启动子区域存在差异甲基化(差异甲基化基因,DMGs),以及2979个差异表达基因(DEGs)。然后,我们使用R包iSubpathwayMiner分别检测了DMGs和DEGs中富集的57个和34个亚通路。基于超几何检验,我们保留了56个与异常甲基化和表达均相关的亚通路用于进一步分析。利用亚通路中基因之间的调控关系构建了一个综合基因调控网络。使用网络中度排名前15%的节点进行生存分析。我们验证了四个DNA甲基化特征(RAC2、PLCB2、VAV1和PARVG)与KIRC的预后高度相关。这些发现表明,DNA甲基化可能成为KIRC的预后预测指标,并可补充组织学预后预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/8e50232a539e/oncotarget-08-5268-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/afec7323c1fd/oncotarget-08-5268-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/0ef0c2c8f23d/oncotarget-08-5268-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/ffbc042be318/oncotarget-08-5268-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/b3e778143f55/oncotarget-08-5268-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/8e50232a539e/oncotarget-08-5268-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/afec7323c1fd/oncotarget-08-5268-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/0ef0c2c8f23d/oncotarget-08-5268-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/ffbc042be318/oncotarget-08-5268-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/b3e778143f55/oncotarget-08-5268-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5830/5354907/8e50232a539e/oncotarget-08-5268-g005.jpg

相似文献

1
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.基于肾透明细胞癌中异常DNA甲基化鉴定预后生物标志物。
Oncotarget. 2017 Jan 17;8(3):5268-5280. doi: 10.18632/oncotarget.14134.
2
Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.基于肾透明细胞癌中甲基化驱动基因的机器学习构建的新型预后预测模型。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201604.
3
Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.基于多组学整合的肾透明细胞癌免疫和炎症相关生物标志物的全面特征分析。
J Transl Med. 2019 May 27;17(1):177. doi: 10.1186/s12967-019-1927-y.
4
A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma.一个包含五个基因甲基化标记的signature 可预测肾透明细胞癌患者的总生存期。
J Clin Lab Anal. 2021 Dec;35(12):e24031. doi: 10.1002/jcla.24031. Epub 2021 Oct 30.
5
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.系统分析剪接变异特征揭示了肾透明细胞癌的预后预测因子。
J Cell Physiol. 2019 Dec;234(12):22753-22764. doi: 10.1002/jcp.28840. Epub 2019 May 29.
6
The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.肾透明细胞癌中有前景的新型生物标志物和候选小分子药物:来自高通量数据生物信息学分析的证据
Mol Genet Genomic Med. 2019 May;7(5):e607. doi: 10.1002/mgg3.607. Epub 2019 Feb 21.
7
Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.肾透明细胞癌中两种新型预后长链非编码RNA的鉴定与验证
Cell Physiol Biochem. 2018;48(6):2549-2562. doi: 10.1159/000492699. Epub 2018 Aug 17.
8
Identification of genes and pathways involved in kidney renal clear cell carcinoma.肾透明细胞癌相关基因和通路的鉴定
BMC Bioinformatics. 2014;15 Suppl 17(Suppl 17):S2. doi: 10.1186/1471-2105-15-S17-S2. Epub 2014 Dec 16.
9
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.通过泛癌筛选发现肾透明细胞癌生存时间的独特蛋白表达特征。
BMC Genomics. 2017 Oct 3;18(Suppl 6):678. doi: 10.1186/s12864-017-4026-6.
10
An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.整合甲基化和基因表达微阵列分析揭示口腔鳞状细胞癌中具有显著预后价值的生物标志物。
Oncol Rep. 2018 Nov;40(5):2637-2647. doi: 10.3892/or.2018.6702. Epub 2018 Sep 12.

引用本文的文献

1
Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer.多组学分析确定TMED2为六种人类癌症亚型中的共享潜在生物标志物。
Int J Gen Med. 2021 Oct 21;14:7025-7042. doi: 10.2147/IJGM.S327367. eCollection 2021.
2
Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.子宫体子宫内膜癌中甲基化驱动基因预后特征及免疫微环境的鉴定
Cancer Cell Int. 2021 Jul 10;21(1):365. doi: 10.1186/s12935-021-02038-z.
3
Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis.

本文引用的文献

1
CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer.CDH1启动子甲基化与乳腺癌患者基因表达降低及预后不良相关。
Oncol Lett. 2016 Apr;11(4):2635-2643. doi: 10.3892/ol.2016.4274. Epub 2016 Feb 24.
2
MCAM and LAMA4 Are Highly Enriched in Tumor Blood Vessels of Renal Cell Carcinoma and Predict Patient Outcome.MCAM和LAMA4在肾细胞癌肿瘤血管中高度富集并可预测患者预后。
Cancer Res. 2016 Apr 15;76(8):2314-26. doi: 10.1158/0008-5472.CAN-15-1364. Epub 2016 Feb 26.
3
Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
肝细胞癌中甲基化调控的差异表达基因及相关通路的鉴定:基于TCGA数据库和生物信息学分析的研究
Front Oncol. 2021 Jun 3;11:636093. doi: 10.3389/fonc.2021.636093. eCollection 2021.
4
A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.基于 9 个差异甲基化 mRNAs 的风险评分模型预测透明细胞肾细胞癌患者的预后。
Dis Markers. 2021 Jan 14;2021:8863799. doi: 10.1155/2021/8863799. eCollection 2021.
5
Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.基于肾透明细胞癌中甲基化驱动基因的机器学习构建的新型预后预测模型。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201604.
6
The long noncoding RNA KCNQ1DN suppresses the survival of renal cell carcinoma cells through downregulating c-Myc.长链非编码RNA KCNQ1DN通过下调c-Myc抑制肾癌细胞的存活。
J Cancer. 2019 Aug 19;10(19):4662-4670. doi: 10.7150/jca.29280. eCollection 2019.
7
In-Depth Bioinformatic Study of the CLDN16 Gene and Protein: Prediction of Subcellular Localization to Mitochondria.CLDN16基因和蛋白质的深入生物信息学研究:线粒体亚细胞定位预测
Medicina (Kaunas). 2019 Jul 26;55(8):409. doi: 10.3390/medicina55080409.
8
Detection of dysregulated competing endogenous RNA modules associated with clear cell kidney carcinoma.检测与透明细胞肾细胞癌相关的失调竞争内源性 RNA 模块。
Mol Med Rep. 2018 Aug;18(2):1963-1972. doi: 10.3892/mmr.2018.9189. Epub 2018 Jun 19.
9
Anti-tumor roles of both strands of the duplex: their targets and are involved in the pathogenesis of renal cell carcinoma.双链的两条链的抗肿瘤作用:它们的靶点参与肾细胞癌的发病机制。
Oncotarget. 2018 Jun 1;9(42):26638-26658. doi: 10.18632/oncotarget.25410.
10
The Role of DNA Methylation in Renal Cell Carcinoma.DNA 甲基化在肾细胞癌中的作用。
Mol Diagn Ther. 2018 Aug;22(4):431-442. doi: 10.1007/s40291-018-0337-9.
长链非编码RNA AFAP1-AS1提示肝细胞癌预后不良,并通过上调RhoA/Rac2信号促进细胞增殖和侵袭。
Int J Oncol. 2016 Apr;48(4):1590-8. doi: 10.3892/ijo.2016.3385. Epub 2016 Feb 8.
4
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies.一种用于预测局限性肾细胞癌手术后复发的 16 基因检测:开发和验证研究。
Lancet Oncol. 2015 Jun;16(6):676-85. doi: 10.1016/S1470-2045(15)70167-1. Epub 2015 May 12.
5
The identification of specific methylation patterns across different cancers.不同癌症中特定甲基化模式的识别。
PLoS One. 2015 Mar 16;10(3):e0120361. doi: 10.1371/journal.pone.0120361. eCollection 2015.
6
EAU guidelines on renal cell carcinoma: 2014 update.EAU 指南:肾细胞癌. 2014 年更新版.
Eur Urol. 2015 May;67(5):913-24. doi: 10.1016/j.eururo.2015.01.005. Epub 2015 Jan 21.
7
Normalization of RNA-seq data using factor analysis of control genes or samples.使用对照基因或样本的因子分析对RNA测序数据进行标准化。
Nat Biotechnol. 2014 Sep;32(9):896-902. doi: 10.1038/nbt.2931. Epub 2014 Aug 24.
8
Vav1 increases Bcl-2 expression by selective activation of Rac2-Akt in leukemia T cells.Vav1通过选择性激活白血病T细胞中的Rac2-Akt来增加Bcl-2表达。
Cell Signal. 2014 Oct;26(10):2202-9. doi: 10.1016/j.cellsig.2014.05.015. Epub 2014 May 29.
9
Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo.Rac2在体内控制肿瘤生长、转移以及M1-M2巨噬细胞分化。
PLoS One. 2014 Apr 25;9(4):e95893. doi: 10.1371/journal.pone.0095893. eCollection 2014.
10
Cancer diagnostic classifiers based on quantitative DNA methylation.基于定量DNA甲基化的癌症诊断分类器。
Expert Rev Mol Diagn. 2014 Apr;14(3):293-305. doi: 10.1586/14737159.2014.897610.